Creating a new type of biodegradable implant for breast reconstruction
Advanced 3D auxetic biodegradable implant for large volume breast reconstruction
This study is testing a new type of biodegradable implant that can help women who need breast reconstruction after cancer surgery, aiming to make the recovery process safer and more effective by better mimicking natural tissue.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia Institute of Technology NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11058138 on NIH RePORTER |
What this research studies
This research focuses on developing an advanced 3D auxetic biodegradable implant designed specifically for large volume breast reconstruction after cancer surgery. The approach involves scaling up a novel auxetic architecture that has shown promise in enhancing tissue regeneration and reducing complications associated with traditional implants. The research will utilize advanced techniques such as Finite Element simulation and mechanical testing to evaluate the implant's performance in mimicking natural tissue properties. By improving the design and functionality of these implants, the goal is to provide a safer and more effective option for patients undergoing breast reconstruction.
Who could benefit from this research
Good fit: Ideal candidates for this research are women who have undergone surgery for breast cancer and are seeking reconstruction options.
Not a fit: Patients who are not undergoing breast reconstruction or those with contraindications to implant surgery may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer breast reconstruction options with fewer complications and improved aesthetic outcomes for patients.
How similar studies have performed: Previous research in tissue engineering and biodegradable implants has shown promise, but this specific approach using auxetic designs is relatively novel.
Where this research is happening
Atlanta, United States
- Georgia Institute of Technology — Atlanta, United States (Active)
Researchers
- Principal investigator: Park, Jeong Hun — Georgia Institute of Technology
- Study coordinator: Park, Jeong Hun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.